Now Available for the Clinic
BioFire® Respiratory 2.1-EZ (RP2.1-EZ) Panel (EUA)**
Authorized by the FDA for the point-of-care space under an Emergency Use Authorization, the BioFire RP2.1-EZ Panel (EUA) identifies a menu of 19 respiratory targets, including SARS-CoV-2, in one multiplex PCR test, with results in about 45 minutes. The BioFire RP2.1-EZ Panel (EUA) is designed to run on the CLIA-waived BioFire® FilmArray® 2.0 EZ Configuration System.
Sample type: nasopharyngeal swab (NPS) in transport media